The IGF-I Signaling Pathway
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
663-669
Author(s):
Luigi Laviola, Annalisa Natalicchio and Francesco Giorgino
The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
671-686
Author(s):
Antonino Belfiore
Physical Activity, Insulin Action, and Diabetes Prevention and Control
Journal:
Current Diabetes Reviews
Volume:
3
Page:
176-184
Author(s):
Sheri R. Colberg
Model-Based Insulin and Nutrition Administration for Tight Glycaemic Control in Critical Care
Journal:
Current Drug Delivery
Volume:
4
Page:
283-296
Author(s):
J. Geoffrey Chase, Geoffrey M. Shaw, Thomas Lotz, Aaron LeCompte, Jason Wong, Jessica Lin, Timothy Lonergan, Michael Willacy and Christopher E. Hann
Basal Bolus Dosing: A Clinical Experience
Journal:
Current Diabetes Reviews
Volume:
1
Page:
215-220
Author(s):
Allen B. King and Dana U. Armstrong
A Critical Review of Atypical Antipsychotic Utilization: Comparing Monotherapy with Polypharmacy and Augmentation
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
313-327
Author(s):
S. M Stahl and M. M. Grady
Naturalistic Studies of Second Generation Antipsychotics in the Treatment of Schizophrenia
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
329-342
Author(s):
C. Simon Sebastian, William Glazer and Peter F. Buckley
Side Effects of Atypical Antipsychotic Drugs
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2219-2229
Author(s):
J. Ananth, S. Parameswaran and S. Gunatilake
Activated T Lymphocytes in Type 2 Diabetes: Implications From in Vitro Studies
Journal:
Current Drug Targets
Volume:
4
Page:
493-503
Author(s):
Frankie B. Stentz and Abbas E. Kitabchi
Role of the Insulin Receptor Variant Forms in Human Metabolic Disorders
Journal:
Current Genomics
Volume:
4
Page:
295-307
Author(s):
Giorgio Sesti